This interactive webinar is designed to support medical oncologists and multidisciplinary teams in confidently interpreting lung cancer molecular pathology reports in real-world clinical practice, particularly in settings without access to a molecular tumour board.
Through real molecular report examples and case-based discussions, the session will focus on identifying actionable mutations, distinguishing clinically relevant variants from non-actionable findings, and translating results into evidence-based treatment decisions to support quality use of medicines and improved patient outcomes.
Beyond the NGS Report
5 Videos
Speakers
Thank you to our Sponsors